Literature DB >> 7719907

Quantitative reverse transcription-PCR analysis of Legionella pneumophila-induced cytokine mRNA in different macrophage populations by high-performance liquid chromatography.

Y Yamamoto1, C Retzlaff, P He, T W Klein, H Friedman.   

Abstract

Cytokine production in macrophages infected by bacteria is critical for the course of infection. However, it is not known how infection of macrophages with opportunistic bacteria leads to cytokine production in different populations of cells. Since it is possible that cytokine genes may be differentially regulated by attachment rather than by active infection, the levels of various cytokine mRNAs were measured in alveolar macrophages (AMs), peritoneal resident macrophages (RMs), and peritoneally elicited macrophages (EMs) interacting with Legionella pneumophila by using cytochalasin D-treated macrophages and a newly developed quantitative reverse transcription-PCR procedure with high-performance liquid chromatographic analysis to determine cytokine mRNA formation. Increased levels of interleukin-1 beta (IL-1 beta), IL-6, tumor necrosis factor alpha, granulocyte-macrophage colony-stimulating factor, and macrophage inflammatory protein 2 mRNAs were quantitated in the macrophages responding to L. pneumophila attachment in vitro. Using this technique, we showed that the three different macrophage populations responded differently to bacterial attachment. We found that the levels of IL-6 and granulocyte-macrophage colony-stimulating factor mRNAs induced by the attachment of L. pneumophila to AMs were significantly lower than the levels in RMs but similar to the levels in EMs. Furthermore, the levels of MIP-2 mRNA in the AMs were found to be higher than those in the RMs, but similar levels were found in EMs. IL-1 beta mRNA levels were higher in both AMs and RMs than in EMs, but tumor necrosis factor alpha levels were not different among the three macrophage populations examined. Thus, the responses of macrophages to bacterial attachment in terms of cytokine mRNA levels were readily quantitated by the reverse transcription-PCR assay. However, the results obtained showed different levels of responsiveness of distinct macrophage populations to L. pneumophila attachment, and this could be related to the characteristic nature of the macrophage type examined.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7719907      PMCID: PMC170094          DOI: 10.1128/cdli.2.1.18-24.1995

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  35 in total

1.  Enzymatic basis for bioenergetic differences of alveolar versus peritoneal macrophages and enzyme regulation by molecular O2.

Authors:  L M Simon; E D Robin; J R Phillips; J Acevedo; S G Axline; J Theodore
Journal:  J Clin Invest       Date:  1977-03       Impact factor: 14.808

2.  Difference in the induction of macrophage interleukin-1 production between viable and killed cells of Listeria monocytogenes.

Authors:  M Mitsuyama; K Igarashi; I Kawamura; T Ohmori; K Nomoto
Journal:  Infect Immun       Date:  1990-05       Impact factor: 3.441

3.  Rapid analysis and purification of polymerase chain reaction products by high-performance liquid chromatography.

Authors:  E D Katz; M W Dong
Journal:  Biotechniques       Date:  1990-05       Impact factor: 1.993

4.  Human alveolar macrophage and blood monocyte interleukin-6 production.

Authors:  R M Kotloff; J Little; J A Elias
Journal:  Am J Respir Cell Mol Biol       Date:  1990-11       Impact factor: 6.914

5.  Characterization of murine lung and peritoneal macrophages.

Authors:  J E Hearst; G A Warr; G J Jakab
Journal:  J Reticuloendothel Soc       Date:  1980-05

6.  Legionnaires' disease bacterium (Legionella pneumophila) multiples intracellularly in human monocytes.

Authors:  M A Horwitz; S C Silverstein
Journal:  J Clin Invest       Date:  1980-09       Impact factor: 14.808

7.  Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction.

Authors:  K E Noonan; C Beck; T A Holzmayer; J E Chin; J S Wunder; I L Andrulis; A F Gazdar; C L Willman; B Griffith; D D Von Hoff; I B Roninson
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

8.  Increased expression of proinflammatory cytokines in chronic lesions of human cutaneous leishmaniasis.

Authors:  P C Melby; F J Andrade-Narvaez; B J Darnell; G Valencia-Pacheco; V V Tryon; A Palomo-Cetina
Journal:  Infect Immun       Date:  1994-03       Impact factor: 3.441

9.  Binding of Legionella pneumophila to macrophages increases cellular cytokine mRNA.

Authors:  Y Yamamoto; S Okubo; T W Klein; K Onozaki; T Saito; H Friedman
Journal:  Infect Immun       Date:  1994-09       Impact factor: 3.441

10.  In vitro responses of guinea pig peritoneal macrophages to Legionella pneumophila.

Authors:  R A Kishimoto; J D White; F G Shirey; V G McGann; R F Berendt; E W Larson; K W Hedlund
Journal:  Infect Immun       Date:  1981-03       Impact factor: 3.441

View more
  11 in total

1.  Differential effects of virulent versus avirulent Legionella pneumophila on chemokine gene expression in murine alveolar macrophages determined by cDNA expression array technique.

Authors:  N Nakachi; K Matsunaga; T W Klein; H Friedman; Y Yamamoto
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

2.  Involvement of mannose receptor in cytokine interleukin-1beta (IL-1beta), IL-6, and granulocyte-macrophage colony-stimulating factor responses, but not in chemokine macrophage inflammatory protein 1beta (MIP-1beta), MIP-2, and KC responses, caused by attachment of Candida albicans to macrophages.

Authors:  Y Yamamoto; T W Klein; H Friedman
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

3.  Legionella pneumophila heat-shock protein-induced increase of interleukin-1 beta mRNA involves protein kinase C signalling in macrophages.

Authors:  C Retzlaff; Y Yamamoto; S Okubo; P S Hoffman; H Friedman; T W Klein
Journal:  Immunology       Date:  1996-10       Impact factor: 7.397

4.  Cytokine response of lymphocytes persistently infected with Chlamydia pneumoniae.

Authors:  Riho Takano; Hiroyuki Yamaguchi; Shigehiro Sugimoto; Shinichi Nakamura; Herman Friedman; Yoshimasa Yamamoto
Journal:  Curr Microbiol       Date:  2005-03-15       Impact factor: 2.188

5.  Induction of cytokine granulocyte-macrophage colony-stimulating factor and chemokine macrophage inflammatory protein 2 mRNAs in macrophages by Legionella pneumophila or Salmonella typhimurium attachment requires different ligand-receptor systems.

Authors:  Y Yamamoto; T W Klein; H Friedman
Journal:  Infect Immun       Date:  1996-08       Impact factor: 3.441

6.  Induction of interleukin-4 (IL-4) by legionella pneumophila infection in BALB/c mice and regulation of tumor necrosis factor alpha, IL-6, and IL-1beta.

Authors:  C Newton; S McHugh; R Widen; N Nakachi; T Klein; H Friedman
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

7.  Differential induction of gamma interferon in Legionella pneumophila-infected macrophages from BALB/c and A/J mice.

Authors:  S Salins; C Newton; R Widen; T W Klein; H Friedman
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

8.  Legionella pneumophila replication in macrophages inhibited by selective immunomodulatory effects on cytokine formation by epigallocatechin gallate, a major form of tea catechins.

Authors:  K Matsunaga; T W Klein; H Friedman; Y Yamamoto
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

9.  Adjuvant effects for oral immunization provided by recombinant Lactobacillus casei secreting biologically active murine interleukin-1{beta}.

Authors:  Akinobu Kajikawa; Kazuya Masuda; Mitsunori Katoh; Shizunobu Igimi
Journal:  Clin Vaccine Immunol       Date:  2009-11-18

10.  Epigallocatechin gallate, a potential immunomodulatory agent of tea components, diminishes cigarette smoke condensate-induced suppression of anti-Legionella pneumophila activity and cytokine responses of alveolar macrophages.

Authors:  Kazuto Matsunaga; Thomas W Klein; Herman Friedman; Yoshimasa Yamamoto
Journal:  Clin Diagn Lab Immunol       Date:  2002-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.